Key result
Highest myocardial contraction fraction tertile is linked to ~74% lower all-cause mortality in HCM.
Why the study?
The study was conducted to evaluate whether myocardial contraction fraction could predict adverse outcomes in patients with hypertrophic cardiomyopathy.
Does higher myocardial contraction fraction (MCF) predict lower mortality in patients with hypertrophic cardiomyopathy?
Population
438 HCM patients
Comparison
Outcomes across myocardial contraction fraction (MCF) tertiles
Design
Retrospective cohort study
Follow-up
1738.2 person-year
Authors
Loading...
May refine HCM risk stratification; hypothesis-generating pending prospective validation.
Cohort (n=438)
No
Does higher myocardial contraction fraction (MCF) predict lower mortality in patients with hypertrophic cardiomyopathy?
Effect estimate: HR 0.26 (95% CI 0.12-0.56)
Absolute Event Rate: 9.5% vs 24.7%
p-value: p=0.001
Myocardial contraction fraction (MCF) is a strong, independent predictor of all-cause and HCM-related mortality in patients with hypertrophic cardiomyopathy, offering a useful noninvasive echocardiographic tool for risk stratification.
Liao et al. (2020) conducted a cohort in Hypertrophic cardiomyopathy (n=438). Highest tertile of myocardial contraction fraction (MCF) vs. Lowest tertile of MCF was evaluated on All-cause mortality (HR 0.26, 95% CI 0.12-0.56, p=0.001). In patients with hypertrophic cardiomyopathy, being in the highest tertile of myocardial contraction fraction significantly reduced the risk of all-cause mortality compared to the lowest tertile (HR 0.26).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: